Mergers and Acquisitions Never End In A Tie
Mergers and Acquisitions Never End In [...]
Have you been lulled into complacency by a system-based government pricing solution?
Have you been lulled into complacency [...]
Understanding Baseline AMP Rules Can Help You Avoid Pricing Decision Disasters
Understanding Baseline AMP Rules Can Help [...]
System-based calculations miss crucial details in government price reporting.
System-based calculations miss crucial details in government price [...]
Have confidence in the data that drives government pricing computations.
Have confidence in the data that [...]
Why Medicaid is a pharma company’s most demanding government program in terms of potential impact and resources.
Why Medicaid is a pharma company’s [...]
Understanding the complexities of implementing a generic pharmaceutical company commercialization plan.
Understanding the complexities of implementing a [...]
Continued Emergence of Drug Price Disclosure Legislation – April 2020
Continued Emergence of Drug Price Disclosure [...]
Avoiding Costly Government Pricing Mistakes
Avoiding Costly Government Pricing Mistakes [...]
Continued Emergence of Drug Price Disclosure Legislation – January 2020
Continued Emergence of Drug [...]
Drug Price Disclosure Legislation – April 2019
Drug Price Disclosure Legislation APRIL 2019 [...]